Keywords
Bacteria
Drug resistance
How to Cite
Abstract
Patients admitted in the Intensive Care Units (ICUs) often experience various oral health issues during their hospitalization, which can lead to a shift in their oral flora from Gram-positive to pathogenic Gram-negative bacteria, including Pseudomonas aeruginosa. Aim: This study aimed to identify the colonization of P. aeruginosa in the oral cavity of ICU patients, as well as to assess its antimicrobial susceptibility profile, phenotypic resistance mechanisms, and biofilm-forming capacity. Methods: Oral cavity samples were collected from patients in ICUs across three public hospitals in Porto Velho, Rondônia, Brazil. Antimicrobial susceptibility testing was performed using the disk diffusion method, phenotypic research on resistance determinants was conducted using a disk method with and without the addition of enzymatic inhibitors, and biofilm formation was assessed by measuring absorbance in microplates. Results: A total of 114 oral cavity samples were obtained, with 28% showing colonization by P. aeruginosa. The antimicrobial susceptibility profile revealed that 93.7% of the isolates were susceptible to Polymyxin B. The highest rate of non-susceptibility was observed with levofloxacin (46.8%), followed by carbapenems: imipenem (43.7%) and meropenem (40.6%). Additionally, 37.5% of the isolates were classified as multidrug-resistant (MDR). In phenotypic research for carbapenemases, 35.7% of the isolates were positive for plasmid-mediated AmpC, and 14.3% were positive for Metallo-β-lactamases. Regarding biofilm production, 75% of the isolates were classified as moderate/strong biofilm producers. Conclusion: Therefore, oral cavity colonization by P. aeruginosa in ICU patients is evident, with notable multidrug resistance to antibiotics, highlighting the need for vigilant monitoring and effective oral hygiene practices for these patients.
References
Tuganbaev T, Yoshida K, Honda K. The effects of oral microbiota on health. Science. 2022 May;376(6596):934-6. doi: 10.1126/science.abn1890.
Leão I, de Carvalho TB, Henriques V, Ferreira C, Sampaio-Maia B, Manaia CM. Pseudomonadota in the oral cavity: a glimpse into the environment-human nexus. Appl Microbiol Biotechnol. 2023 Feb;107(2-3):517-34. doi: 10.1007/s00253-022-12333-y. Epub 2022 Dec 26.
Willis JR, Gabaldón T. The human oral microbiome in health and disease: from sequences to ecosystems. Microorganisms. 2020 Feb;8(2):308. doi: 10.3390/microorganisms8020308.
Arkia M, Rezaei J, Salari N, Vaziri S, Abdi A. Oral status and affecting factors in Iranian ICU patients: a cross-sectional study. BMC Oral Health. 2023 Mar;23(1):154. doi: 10.1186/s12903-023-02867-6.
Miranda AF, de Paula RM, de Castro Piau CG, Costa PP, Bezerra AC. Oral care practices for patients in intensive care units: a pilot survey. Indian J Crit Care Med. 2016 May;20(5):267-73. doi: 10.4103/0972-5229.182203.
Singh P, Arshad Z, Srivastava VK, Singh GP, Gangwar RS. Efficacy of oral care protocols in the prevention of ventilator-associated pneumonia in mechanically ventilated patients. Cureus. 2022 Apr;14(4):e23750. doi: 10.7759/cureus.23750.
Diggle SP, Whiteley M. Microbe Profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat. Microbiology (Reading). 2020 Jan;166(1):30-3. doi: 10.1099/mic.0.000860. Erratum in: Microbiology (Reading). 2021 Aug;167(8). doi: 10.1099/mic.0.001073.
Díaz Santos E, Mora Jiménez C, Del Río-Carbajo L, Vidal-Cortés P. Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections. Med Intensiva (Engl Ed). 2022 Sep;46(9):508-20. doi: 10.1016/j.medine.2022.06.014.
Ribeiro ACDS, Crozatti MTL, Silva AAD, Macedo RS, Machado AMO, Silva ATA. Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption. Rev Soc Bras Med Trop. 2019 Dec;53:e20180498. doi: 10.1590/0037-8682-0498-2018.
Alonso B, Fernández-Barat L, Di Domenico EG, Marín M, Cercenado E, Merino I, et al. Characterization of the virulence of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia. BMC Infect Dis. 2020 Dec;20(1):909. doi: 10.1186/s12879-020-05534-1. Erratum in: BMC Infect Dis. 2020 Dec;20(1):951. doi: 10.1186/s12879-020-05691-3.
Foucrier A, Dessalle T, Tuffet S, Federici L, Dahyot-Fizelier C, Barbier F, et al. Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial. Crit Care. 2023 May;27(1):211. doi: 10.1186/s13054-023-04457-y.
Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2018 Jul 4;7:79. doi: 10.1186/s13756-018-0370-9.
WHO Bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024 [cited 2024 jul 6]. Available from: https://www.who.int/publications/i/item/9789240093461.
Hammoudi Halat D, Ayoub Moubareck C. The intriguing carbapenemases of Pseudomonas aeruginosa: current status, genetic profile, and global epidemiology. Yale J Biol Med. 2022 Dec;95(4):507-15.
Glen KA, Lamont IL. β-lactam resistance in Pseudomonas aeruginosa: current status, future prospects. Pathogens. 2021 Dec;10(12):1638. doi: 10.3390/pathogens10121638.
Giani T, Arena F, Pollini S, Di Pilato V, D'Andrea MM, Henrici De Angelis L, et al. Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers. J Antimicrob Chemother. 2018 Mar;73(3):664-71. doi: 10.1093/jac/dkx453.
Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, et al. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. Lancet Microbe. 2023 Mar;4(3):e159-70. doi: 10.1016/S2666-5247(22)00329-9.
Shortridge D, Gales AC, Streit JM, Huband MD, Tsakris A, Jones RN. Geographic and temporal patterns of antimicrobial resistance in Pseudomonas aeruginosa over 20 years from the SENTRY antimicrobial surveillance program, 1997-2016. Open Forum Infect Dis. 2019 Mar;6(Suppl 1):S63-8. doi: 10.1093/ofid/ofy343.
Pottier M, Castagnet S, Gravey F, Leduc G, Sévin C, Petry S, et al. Antimicrobial resistance and genetic diversity of Pseudomonas aeruginosa strains isolated from equine and other veterinary samples. Pathogens. 2022 Dec;12(1):64. doi: 10.3390/pathogens12010064.
Arruda A, Ferreira GS, Lima NCDS, Santos Júnior AD, Custódio MGF, Benevides-Matos N, et al. A simple methodology to collect culturable bacteria from feces of Anopheles darlingi (Diptera: Culicidae). J Microbiol Methods. 2017 Oct;141:115-7. doi: 10.1016/j.mimet.2017.08.004.
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27.
Alvim DCSS, Ferreira AFM, Leal MA, Oliveira LMA, Botelho AMN, Botelho ACN, et al. Biofilm production and distribution of pilus variants among Streptococcus agalactiae isolated from human and animal sources. Biofouling. 2019 Sep;35(8):938-44. doi: 10.1080/08927014.2019.1678592.
Bratić V, Lukić A, Bedenić B, Bjelanović I, Bevanda M, Mihaljević S, et al. Oral cavity colonization with multidrug-resistant gram-negative bacteria after preoperative prophylactic use of antibiotics as a risk factor for ventilator-associated pneumonia. Psychiatr Danub. 2021 Dec;33(Suppl 13):247-54.
Gupta A, Gupta A, Singh TK, Saxsena A. Role of oral care to prevent VAP in mechanically ventilated Intensive care unit patients. Saudi J Anaesth. 2016 Jan-Mar;10(1):95-7. doi: 10.4103/1658-354X.169484.
Rathbun KP, Bourgault AM, Sole ML. Oral microbes in hospital-acquired pneumonia: practice and research implications. Crit Care Nurse. 2022 Jun;42(3):47-54. doi: 10.4037/ccn2022672.
Kanafani ZA, Sleiman A, Frem JA, Doumat G, Gharamti A, El Hafi B, et al. Molecular characterization and differential effects of levofloxacin and ciprofloxacin on the potential for developing quinolone resistance among clinical Pseudomonas aeruginosa isolates. Front Microbiol. 2023 Sep;14:1209224. doi: 10.3389/fmicb.2023.1209224.
Gaetti-Jardim EC, Marqueti AC, Faverani LP, Gaetti-Jardim Jr E. Antimicrobial resistance of aerobes and facultative anaerobes isolated from the oral cavity. J Appl Oral Sci. 2010 Dec;18(6):551-9. doi: 10.1590/s1678-77572010000600004.
Haruta A, Kawada-Matsuo M, Le MN, Yoshikawa M, Kajihara T, Yahara K, et al. Disinfectant susceptibility of third-generation-cephalosporin/carbapenem-resistant gram-negative bacteria isolated from the oral cavity of residents of long-term-care facilities. Appl Environ Microbiol. 2023 Jan;89(1):e0171222. doi: 10.1128/aem.01712-22. Epub 2022 Dec 14.
Karlowsky JA, Wise MG, Hsieh TC, Lu HC, Chen WT, Cheng MH, et al. Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan-SMART 2012-2021. J Glob Antimicrob Resist. 2023 Sep;34:106-12. doi: 10.1016/j.jgar.2023.06.013.
Aruhomukama D. Review of phenotypic assays for detection of extended-spectrum β-lactamases and carbapenemases: a microbiology laboratory bench guide. Afr Health Sci. 2020 Sep;20(3):1090-108. doi: 10.4314/ahs.v20i3.11.
Garba Z, Kaboré B, Bonkoungou IJO, Natama MH, Rouamba T, Haukka K, et al. Phenotypic detection of carbapenemase and AmpC-β-Lactamase production among extended spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella spp. Isolated from clinical specimens. Antibiotics (Basel). 2023 Dec;13(1):31. doi: 10.3390/antibiotics13010031.
Marino PJ, Wise MP, Smith A, Marchesi JR, Riggio MP, Lewis MAO, et al. Community analysis of dental plaque and endotracheal tube biofilms from mechanically ventilated patients. J Crit Care. 2017 Jun;39:149-55. doi: 10.1016/j.jcrc.2017.02.020.
Vieira Colombo AP, Magalhães CB, Hartenbach FA, Martins do Souto R, Maciel da Silva-Boghossian C. Periodontal-disease-associated biofilm: a reservoir for pathogens of medical importance. Microb Pathog. 2016 May;94:27-34. doi: 10.1016/j.micpath.2015.09.009. Epub 2015 Sep 28.
Javadinia SA, Kuchi Z, Saadatju A, Tabasi M, Adib-Hajbaghery M. Oral care in trauma patients admitted to the ICU: viewpoints of ICU nurses. Trauma Mon. 2014 Apr;19(2):e15110. doi: 10.5812/traumamon.15110.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Marcos Eduardo Passos da Silva, Luccas Manoel de Melo Suica, Renata Santos Rodrigues, Izabelly Vitória Gotara Ramos, Anjo Gabriel Carvalho, Nucia Cristiane da Silva Lima, Mayra Gyovana Leite Belém, Rosimar Pires Esquerdo, Najla Benevides Matos
Downloads
